1. Hayama, Tamuro, Hama, Kotaro, Ozawa, Tsuyoshi, Misawa, Takeyuki, Fukagawa, Takeo. 2023. Ceramide synthase CERS4 gene downregulation is associated with KRAS mutation in colorectal cancer. In Scientific reports, 13, 16249. doi:10.1038/s41598-023-43557-1. https://pubmed.ncbi.nlm.nih.gov/37758931/
2. Luo, Yuhong, Yang, Shoumei, Wu, Xuan, Liu, Weiwei, Gonzalez, Frank J. 2021. Intestinal MYC modulates obesity-related metabolic dysfunction. In Nature metabolism, 3, 923-939. doi:10.1038/s42255-021-00421-8. https://pubmed.ncbi.nlm.nih.gov/34211180/
3. Kim, Su-Jeong, Seo, Incheol, Kim, Min Hee, Kim, Shin, Park, Woo-Jae. 2023. Ceramide synthase 4 overexpression exerts oncogenic properties in breast cancer. In Lipids in health and disease, 22, 183. doi:10.1186/s12944-023-01930-z. https://pubmed.ncbi.nlm.nih.gov/37885013/
4. Shao, Congxiang, Ye, Junzhao, Dong, Zhi, Hu, Shixian, Zhong, Bihui. 2024. Phospholipid metabolism-related genotypes of PLA2R1 and CERS4 contribute to nonobese MASLD. In Hepatology communications, 8, . doi:10.1097/HC9.0000000000000388. https://pubmed.ncbi.nlm.nih.gov/38836837/
5. Gruzdeva, Olga, Dyleva, Yulia, Belik, Ekaterina, Fanaskova, Elena, Barbarash, Olga. 2023. Expression of Ceramide-Metabolizing Enzymes in the Heart Adipose Tissue of Cardiovascular Disease Patients. In International journal of molecular sciences, 24, . doi:10.3390/ijms24119494. https://pubmed.ncbi.nlm.nih.gov/37298446/
6. Wegner, Marthe-Susanna, Wanger, Ruth Anna, Oertel, Stephanie, Geisslinger, Gerd, Grösch, Sabine. 2014. Ceramide synthases CerS4 and CerS5 are upregulated by 17β-estradiol and GPER1 via AP-1 in human breast cancer cells. In Biochemical pharmacology, 92, 577-89. doi:10.1016/j.bcp.2014.10.007. https://pubmed.ncbi.nlm.nih.gov/25451689/
智鼠故事 
